- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
A companion diagnostic is a diagnostic test used as a companion to a therapeutic drug to determine its applicability to a specific person.
According to our latest study, the global Oncology Companion Diagnostic market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Oncology Companion Diagnostic market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Oncology Companion Diagnostic market size and forecasts, in consumption value ($ Million), 2018-2029
Global Oncology Companion Diagnostic market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Oncology Companion Diagnostic market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Oncology Companion Diagnostic market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oncology Companion Diagnostic
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oncology Companion Diagnostic market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Agilent Technologies, Inc., Illumina, Inc., Qiagen N.V., Thermo Fisher Scientific Inc. and F. Hoffmann-La Roche Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Oncology Companion Diagnostic market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Polymerase Chain Reaction (PCR)
Next-Generation Sequencing (NGS)
Immunohistochemistry (IHC)
In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
Others
Market segment by Application
Hospital
Pathology/Diagnostic Laboratory
Academic Medical Center
Market segment by players, this report covers
Agilent Technologies, Inc.
Illumina, Inc.
Qiagen N.V.
Thermo Fisher Scientific Inc.
F. Hoffmann-La Roche Ltd.
ARUP Laboratories
Abbott
Myriad Genetics, Inc.
bioMérieux SA
Invivoscribe, Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Oncology Companion Diagnostic product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Oncology Companion Diagnostic, with revenue, gross margin and global market share of Oncology Companion Diagnostic from 2018 to 2023.
Chapter 3, the Oncology Companion Diagnostic competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Oncology Companion Diagnostic market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Oncology Companion Diagnostic.
Chapter 13, to describe Oncology Companion Diagnostic research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Oncology Companion Diagnostic
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Oncology Companion Diagnostic by Type
1.3.1 Overview: Global Oncology Companion Diagnostic Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Oncology Companion Diagnostic Consumption Value Market Share by Type in 2022
1.3.3 Polymerase Chain Reaction (PCR)
1.3.4 Next-Generation Sequencing (NGS)
1.3.5 Immunohistochemistry (IHC)
1.3.6 In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
1.3.7 Others
1.4 Global Oncology Companion Diagnostic Market by Application
1.4.1 Overview: Global Oncology Companion Diagnostic Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Pathology/Diagnostic Laboratory
1.4.4 Academic Medical Center
1.5 Global Oncology Companion Diagnostic Market Size & Forecast
1.6 Global Oncology Companion Diagnostic Market Size and Forecast by Region
1.6.1 Global Oncology Companion Diagnostic Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Oncology Companion Diagnostic Market Size by Region, (2018-2029)
1.6.3 North America Oncology Companion Diagnostic Market Size and Prospect (2018-2029)
1.6.4 Europe Oncology Companion Diagnostic Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Oncology Companion Diagnostic Market Size and Prospect (2018-2029)
1.6.6 South America Oncology Companion Diagnostic Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Oncology Companion Diagnostic Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Agilent Technologies, Inc.
2.1.1 Agilent Technologies, Inc. Details
2.1.2 Agilent Technologies, Inc. Major Business
2.1.3 Agilent Technologies, Inc. Oncology Companion Diagnostic Product and Solutions
2.1.4 Agilent Technologies, Inc. Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Agilent Technologies, Inc. Recent Developments and Future Plans
2.2 Illumina, Inc.
2.2.1 Illumina, Inc. Details
2.2.2 Illumina, Inc. Major Business
2.2.3 Illumina, Inc. Oncology Companion Diagnostic Product and Solutions
2.2.4 Illumina, Inc. Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Illumina, Inc. Recent Developments and Future Plans
2.3 Qiagen N.V.
2.3.1 Qiagen N.V. Details
2.3.2 Qiagen N.V. Major Business
2.3.3 Qiagen N.V. Oncology Companion Diagnostic Product and Solutions
2.3.4 Qiagen N.V. Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Qiagen N.V. Recent Developments and Future Plans
2.4 Thermo Fisher Scientific Inc.
2.4.1 Thermo Fisher Scientific Inc. Details
2.4.2 Thermo Fisher Scientific Inc. Major Business
2.4.3 Thermo Fisher Scientific Inc. Oncology Companion Diagnostic Product and Solutions
2.4.4 Thermo Fisher Scientific Inc. Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans
2.5 F. Hoffmann-La Roche Ltd.
2.5.1 F. Hoffmann-La Roche Ltd. Details
2.5.2 F. Hoffmann-La Roche Ltd. Major Business
2.5.3 F. Hoffmann-La Roche Ltd. Oncology Companion Diagnostic Product and Solutions
2.5.4 F. Hoffmann-La Roche Ltd. Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 F. Hoffmann-La Roche Ltd. Recent Developments and Future Plans
2.6 ARUP Laboratories
2.6.1 ARUP Laboratories Details
2.6.2 ARUP Laboratories Major Business
2.6.3 ARUP Laboratories Oncology Companion Diagnostic Product and Solutions
2.6.4 ARUP Laboratories Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 ARUP Laboratories Recent Developments and Future Plans
2.7 Abbott
2.7.1 Abbott Details
2.7.2 Abbott Major Business
2.7.3 Abbott Oncology Companion Diagnostic Product and Solutions
2.7.4 Abbott Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Abbott Recent Developments and Future Plans
2.8 Myriad Genetics, Inc.
2.8.1 Myriad Genetics, Inc. Details
2.8.2 Myriad Genetics, Inc. Major Business
2.8.3 Myriad Genetics, Inc. Oncology Companion Diagnostic Product and Solutions
2.8.4 Myriad Genetics, Inc. Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Myriad Genetics, Inc. Recent Developments and Future Plans
2.9 bioMérieux SA
2.9.1 bioMérieux SA Details
2.9.2 bioMérieux SA Major Business
2.9.3 bioMérieux SA Oncology Companion Diagnostic Product and Solutions
2.9.4 bioMérieux SA Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 bioMérieux SA Recent Developments and Future Plans
2.10 Invivoscribe, Inc.
2.10.1 Invivoscribe, Inc. Details
2.10.2 Invivoscribe, Inc. Major Business
2.10.3 Invivoscribe, Inc. Oncology Companion Diagnostic Product and Solutions
2.10.4 Invivoscribe, Inc. Oncology Companion Diagnostic Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Invivoscribe, Inc. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Oncology Companion Diagnostic Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Oncology Companion Diagnostic by Company Revenue
3.2.2 Top 3 Oncology Companion Diagnostic Players Market Share in 2022
3.2.3 Top 6 Oncology Companion Diagnostic Players Market Share in 2022
3.3 Oncology Companion Diagnostic Market: Overall Company Footprint Analysis
3.3.1 Oncology Companion Diagnostic Market: Region Footprint
3.3.2 Oncology Companion Diagnostic Market: Company Product Type Footprint
3.3.3 Oncology Companion Diagnostic Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Oncology Companion Diagnostic Consumption Value and Market Share by Type (2018-2023)
4.2 Global Oncology Companion Diagnostic Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Oncology Companion Diagnostic Consumption Value Market Share by Application (2018-2023)
5.2 Global Oncology Companion Diagnostic Market Forecast by Application (2024-2029)
6 North America
6.1 North America Oncology Companion Diagnostic Consumption Value by Type (2018-2029)
6.2 North America Oncology Companion Diagnostic Consumption Value by Application (2018-2029)
6.3 North America Oncology Companion Diagnostic Market Size by Country
6.3.1 North America Oncology Companion Diagnostic Consumption Value by Country (2018-2029)
6.3.2 United States Oncology Companion Diagnostic Market Size and Forecast (2018-2029)
6.3.3 Canada Oncology Companion Diagnostic Market Size and Forecast (2018-2029)
6.3.4 Mexico Oncology Companion Diagnostic Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Oncology Companion Diagnostic Consumption Value by Type (2018-2029)
7.2 Europe Oncology Companion Diagnostic Consumption Value by Application (2018-2029)
7.3 Europe Oncology Companion Diagnostic Market Size by Country
7.3.1 Europe Oncology Companion Diagnostic Consumption Value by Country (2018-2029)
7.3.2 Germany Oncology Companion Diagnostic Market Size and Forecast (2018-2029)
7.3.3 France Oncology Companion Diagnostic Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Oncology Companion Diagnostic Market Size and Forecast (2018-2029)
7.3.5 Russia Oncology Companion Diagnostic Market Size and Forecast (2018-2029)
7.3.6 Italy Oncology Companion Diagnostic Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Oncology Companion Diagnostic Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Oncology Companion Diagnostic Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Oncology Companion Diagnostic Market Size by Region
8.3.1 Asia-Pacific Oncology Companion Diagnostic Consumption Value by Region (2018-2029)
8.3.2 China Oncology Companion Diagnostic Market Size and Forecast (2018-2029)
8.3.3 Japan Oncology Companion Diagnostic Market Size and Forecast (2018-2029)
8.3.4 South Korea Oncology Companion Diagnostic Market Size and Forecast (2018-2029)
8.3.5 India Oncology Companion Diagnostic Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Oncology Companion Diagnostic Market Size and Forecast (2018-2029)
8.3.7 Australia Oncology Companion Diagnostic Market Size and Forecast (2018-2029)
9 South America
9.1 South America Oncology Companion Diagnostic Consumption Value by Type (2018-2029)
9.2 South America Oncology Companion Diagnostic Consumption Value by Application (2018-2029)
9.3 South America Oncology Companion Diagnostic Market Size by Country
9.3.1 South America Oncology Companion Diagnostic Consumption Value by Country (2018-2029)
9.3.2 Brazil Oncology Companion Diagnostic Market Size and Forecast (2018-2029)
9.3.3 Argentina Oncology Companion Diagnostic Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Oncology Companion Diagnostic Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Oncology Companion Diagnostic Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Oncology Companion Diagnostic Market Size by Country
10.3.1 Middle East & Africa Oncology Companion Diagnostic Consumption Value by Country (2018-2029)
10.3.2 Turkey Oncology Companion Diagnostic Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Oncology Companion Diagnostic Market Size and Forecast (2018-2029)
10.3.4 UAE Oncology Companion Diagnostic Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Oncology Companion Diagnostic Market Drivers
11.2 Oncology Companion Diagnostic Market Restraints
11.3 Oncology Companion Diagnostic Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Oncology Companion Diagnostic Industry Chain
12.2 Oncology Companion Diagnostic Upstream Analysis
12.3 Oncology Companion Diagnostic Midstream Analysis
12.4 Oncology Companion Diagnostic Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Oncology Companion Diagnostic Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Oncology Companion Diagnostic Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Oncology Companion Diagnostic Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Oncology Companion Diagnostic Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Agilent Technologies, Inc. Company Information, Head Office, and Major Competitors
Table 6. Agilent Technologies, Inc. Major Business
Table 7. Agilent Technologies, Inc. Oncology Companion Diagnostic Product and Solutions
Table 8. Agilent Technologies, Inc. Oncology Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Agilent Technologies, Inc. Recent Developments and Future Plans
Table 10. Illumina, Inc. Company Information, Head Office, and Major Competitors
Table 11. Illumina, Inc. Major Business
Table 12. Illumina, Inc. Oncology Companion Diagnostic Product and Solutions
Table 13. Illumina, Inc. Oncology Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Illumina, Inc. Recent Developments and Future Plans
Table 15. Qiagen N.V. Company Information, Head Office, and Major Competitors
Table 16. Qiagen N.V. Major Business
Table 17. Qiagen N.V. Oncology Companion Diagnostic Product and Solutions
Table 18. Qiagen N.V. Oncology Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Qiagen N.V. Recent Developments and Future Plans
Table 20. Thermo Fisher Scientific Inc. Company Information, Head Office, and Major Competitors
Table 21. Thermo Fisher Scientific Inc. Major Business
Table 22. Thermo Fisher Scientific Inc. Oncology Companion Diagnostic Product and Solutions
Table 23. Thermo Fisher Scientific Inc. Oncology Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Thermo Fisher Scientific Inc. Recent Developments and Future Plans
Table 25. F. Hoffmann-La Roche Ltd. Company Information, Head Office, and Major Competitors
Table 26. F. Hoffmann-La Roche Ltd. Major Business
Table 27. F. Hoffmann-La Roche Ltd. Oncology Companion Diagnostic Product and Solutions
Table 28. F. Hoffmann-La Roche Ltd. Oncology Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. F. Hoffmann-La Roche Ltd. Recent Developments and Future Plans
Table 30. ARUP Laboratories Company Information, Head Office, and Major Competitors
Table 31. ARUP Laboratories Major Business
Table 32. ARUP Laboratories Oncology Companion Diagnostic Product and Solutions
Table 33. ARUP Laboratories Oncology Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. ARUP Laboratories Recent Developments and Future Plans
Table 35. Abbott Company Information, Head Office, and Major Competitors
Table 36. Abbott Major Business
Table 37. Abbott Oncology Companion Diagnostic Product and Solutions
Table 38. Abbott Oncology Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Abbott Recent Developments and Future Plans
Table 40. Myriad Genetics, Inc. Company Information, Head Office, and Major Competitors
Table 41. Myriad Genetics, Inc. Major Business
Table 42. Myriad Genetics, Inc. Oncology Companion Diagnostic Product and Solutions
Table 43. Myriad Genetics, Inc. Oncology Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Myriad Genetics, Inc. Recent Developments and Future Plans
Table 45. bioMérieux SA Company Information, Head Office, and Major Competitors
Table 46. bioMérieux SA Major Business
Table 47. bioMérieux SA Oncology Companion Diagnostic Product and Solutions
Table 48. bioMérieux SA Oncology Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. bioMérieux SA Recent Developments and Future Plans
Table 50. Invivoscribe, Inc. Company Information, Head Office, and Major Competitors
Table 51. Invivoscribe, Inc. Major Business
Table 52. Invivoscribe, Inc. Oncology Companion Diagnostic Product and Solutions
Table 53. Invivoscribe, Inc. Oncology Companion Diagnostic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Invivoscribe, Inc. Recent Developments and Future Plans
Table 55. Global Oncology Companion Diagnostic Revenue (USD Million) by Players (2018-2023)
Table 56. Global Oncology Companion Diagnostic Revenue Share by Players (2018-2023)
Table 57. Breakdown of Oncology Companion Diagnostic by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in Oncology Companion Diagnostic, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 59. Head Office of Key Oncology Companion Diagnostic Players
Table 60. Oncology Companion Diagnostic Market: Company Product Type Footprint
Table 61. Oncology Companion Diagnostic Market: Company Product Application Footprint
Table 62. Oncology Companion Diagnostic New Market Entrants and Barriers to Market Entry
Table 63. Oncology Companion Diagnostic Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global Oncology Companion Diagnostic Consumption Value (USD Million) by Type (2018-2023)
Table 65. Global Oncology Companion Diagnostic Consumption Value Share by Type (2018-2023)
Table 66. Global Oncology Companion Diagnostic Consumption Value Forecast by Type (2024-2029)
Table 67. Global Oncology Companion Diagnostic Consumption Value by Application (2018-2023)
Table 68. Global Oncology Companion Diagnostic Consumption Value Forecast by Application (2024-2029)
Table 69. North America Oncology Companion Diagnostic Consumption Value by Type (2018-2023) & (USD Million)
Table 70. North America Oncology Companion Diagnostic Consumption Value by Type (2024-2029) & (USD Million)
Table 71. North America Oncology Companion Diagnostic Consumption Value by Application (2018-2023) & (USD Million)
Table 72. North America Oncology Companion Diagnostic Consumption Value by Application (2024-2029) & (USD Million)
Table 73. North America Oncology Companion Diagnostic Consumption Value by Country (2018-2023) & (USD Million)
Table 74. North America Oncology Companion Diagnostic Consumption Value by Country (2024-2029) & (USD Million)
Table 75. Europe Oncology Companion Diagnostic Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Europe Oncology Companion Diagnostic Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Europe Oncology Companion Diagnostic Consumption Value by Application (2018-2023) & (USD Million)
Table 78. Europe Oncology Companion Diagnostic Consumption Value by Application (2024-2029) & (USD Million)
Table 79. Europe Oncology Companion Diagnostic Consumption Value by Country (2018-2023) & (USD Million)
Table 80. Europe Oncology Companion Diagnostic Consumption Value by Country (2024-2029) & (USD Million)
Table 81. Asia-Pacific Oncology Companion Diagnostic Consumption Value by Type (2018-2023) & (USD Million)
Table 82. Asia-Pacific Oncology Companion Diagnostic Consumption Value by Type (2024-2029) & (USD Million)
Table 83. Asia-Pacific Oncology Companion Diagnostic Consumption Value by Application (2018-2023) & (USD Million)
Table 84. Asia-Pacific Oncology Companion Diagnostic Consumption Value by Application (2024-2029) & (USD Million)
Table 85. Asia-Pacific Oncology Companion Diagnostic Consumption Value by Region (2018-2023) & (USD Million)
Table 86. Asia-Pacific Oncology Companion Diagnostic Consumption Value by Region (2024-2029) & (USD Million)
Table 87. South America Oncology Companion Diagnostic Consumption Value by Type (2018-2023) & (USD Million)
Table 88. South America Oncology Companion Diagnostic Consumption Value by Type (2024-2029) & (USD Million)
Table 89. South America Oncology Companion Diagnostic Consumption Value by Application (2018-2023) & (USD Million)
Table 90. South America Oncology Companion Diagnostic Consumption Value by Application (2024-2029) & (USD Million)
Table 91. South America Oncology Companion Diagnostic Consumption Value by Country (2018-2023) & (USD Million)
Table 92. South America Oncology Companion Diagnostic Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Middle East & Africa Oncology Companion Diagnostic Consumption Value by Type (2018-2023) & (USD Million)
Table 94. Middle East & Africa Oncology Companion Diagnostic Consumption Value by Type (2024-2029) & (USD Million)
Table 95. Middle East & Africa Oncology Companion Diagnostic Consumption Value by Application (2018-2023) & (USD Million)
Table 96. Middle East & Africa Oncology Companion Diagnostic Consumption Value by Application (2024-2029) & (USD Million)
Table 97. Middle East & Africa Oncology Companion Diagnostic Consumption Value by Country (2018-2023) & (USD Million)
Table 98. Middle East & Africa Oncology Companion Diagnostic Consumption Value by Country (2024-2029) & (USD Million)
Table 99. Oncology Companion Diagnostic Raw Material
Table 100. Key Suppliers of Oncology Companion Diagnostic Raw Materials
List of Figures
Figure 1. Oncology Companion Diagnostic Picture
Figure 2. Global Oncology Companion Diagnostic Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Oncology Companion Diagnostic Consumption Value Market Share by Type in 2022
Figure 4. Polymerase Chain Reaction (PCR)
Figure 5. Next-Generation Sequencing (NGS)
Figure 6. Immunohistochemistry (IHC)
Figure 7. In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)
Figure 8. Others
Figure 9. Global Oncology Companion Diagnostic Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 10. Oncology Companion Diagnostic Consumption Value Market Share by Application in 2022
Figure 11. Hospital Picture
Figure 12. Pathology/Diagnostic Laboratory Picture
Figure 13. Academic Medical Center Picture
Figure 14. Global Oncology Companion Diagnostic Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Oncology Companion Diagnostic Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Market Oncology Companion Diagnostic Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 17. Global Oncology Companion Diagnostic Consumption Value Market Share by Region (2018-2029)
Figure 18. Global Oncology Companion Diagnostic Consumption Value Market Share by Region in 2022
Figure 19. North America Oncology Companion Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 20. Europe Oncology Companion Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 21. Asia-Pacific Oncology Companion Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 22. South America Oncology Companion Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 23. Middle East and Africa Oncology Companion Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 24. Global Oncology Companion Diagnostic Revenue Share by Players in 2022
Figure 25. Oncology Companion Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 26. Global Top 3 Players Oncology Companion Diagnostic Market Share in 2022
Figure 27. Global Top 6 Players Oncology Companion Diagnostic Market Share in 2022
Figure 28. Global Oncology Companion Diagnostic Consumption Value Share by Type (2018-2023)
Figure 29. Global Oncology Companion Diagnostic Market Share Forecast by Type (2024-2029)
Figure 30. Global Oncology Companion Diagnostic Consumption Value Share by Application (2018-2023)
Figure 31. Global Oncology Companion Diagnostic Market Share Forecast by Application (2024-2029)
Figure 32. North America Oncology Companion Diagnostic Consumption Value Market Share by Type (2018-2029)
Figure 33. North America Oncology Companion Diagnostic Consumption Value Market Share by Application (2018-2029)
Figure 34. North America Oncology Companion Diagnostic Consumption Value Market Share by Country (2018-2029)
Figure 35. United States Oncology Companion Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 36. Canada Oncology Companion Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 37. Mexico Oncology Companion Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 38. Europe Oncology Companion Diagnostic Consumption Value Market Share by Type (2018-2029)
Figure 39. Europe Oncology Companion Diagnostic Consumption Value Market Share by Application (2018-2029)
Figure 40. Europe Oncology Companion Diagnostic Consumption Value Market Share by Country (2018-2029)
Figure 41. Germany Oncology Companion Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 42. France Oncology Companion Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 43. United Kingdom Oncology Companion Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 44. Russia Oncology Companion Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 45. Italy Oncology Companion Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 46. Asia-Pacific Oncology Companion Diagnostic Consumption Value Market Share by Type (2018-2029)
Figure 47. Asia-Pacific Oncology Companion Diagnostic Consumption Value Market Share by Application (2018-2029)
Figure 48. Asia-Pacific Oncology Companion Diagnostic Consumption Value Market Share by Region (2018-2029)
Figure 49. China Oncology Companion Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 50. Japan Oncology Companion Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 51. South Korea Oncology Companion Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 52. India Oncology Companion Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 53. Southeast Asia Oncology Companion Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 54. Australia Oncology Companion Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 55. South America Oncology Companion Diagnostic Consumption Value Market Share by Type (2018-2029)
Figure 56. South America Oncology Companion Diagnostic Consumption Value Market Share by Application (2018-2029)
Figure 57. South America Oncology Companion Diagnostic Consumption Value Market Share by Country (2018-2029)
Figure 58. Brazil Oncology Companion Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 59. Argentina Oncology Companion Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 60. Middle East and Africa Oncology Companion Diagnostic Consumption Value Market Share by Type (2018-2029)
Figure 61. Middle East and Africa Oncology Companion Diagnostic Consumption Value Market Share by Application (2018-2029)
Figure 62. Middle East and Africa Oncology Companion Diagnostic Consumption Value Market Share by Country (2018-2029)
Figure 63. Turkey Oncology Companion Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 64. Saudi Arabia Oncology Companion Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 65. UAE Oncology Companion Diagnostic Consumption Value (2018-2029) & (USD Million)
Figure 66. Oncology Companion Diagnostic Market Drivers
Figure 67. Oncology Companion Diagnostic Market Restraints
Figure 68. Oncology Companion Diagnostic Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Oncology Companion Diagnostic in 2022
Figure 71. Manufacturing Process Analysis of Oncology Companion Diagnostic
Figure 72. Oncology Companion Diagnostic Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
